PharmaResearch Announces ‘Open Innovation Day’ Running Until September 30 to Foster New Partnerships
PharmaResearch, a company specializing in regenerative medicine (CEO Kim Thinkyou, Kang Ki-seock), announced that it will host the ‘Open Innovation Day’. This initiative aims to foster collaborations in innovative technologies across the aesthetic medical device, pharmaceuticals, biotechnology sectors, both domestically and internationally.
PharmaResearch is seeking partnerships in several key areas, including • facial aesthetics, • body contouring, • aesthetic devices and technology, and • treatments for hair loss, obesity, and sarcopenia. Medical device, Pharmaceutical and biotechnology companies from around the world with innovative technologies and expertise in these fields are encouraged to apply.
PharmaResearch is actively seeking to establish various forms of partnerships with selected companies, including licensing agreements, joint development initiatives, and strategic investments.
A representative from PharmaResearch stated, “The Open Innovation Day is designed to support the continuous growth of companies with innovative ideas and technologies through collaboration. We will continue identifying promising companies and establishing cooperative frameworks for mutual growth.”
Applications for participation are open from August 15 to September 30. Detailed information about the ‘Open Innovation Day’ can be found in the notice section on the PharmaResearch website (https://pharmaresearch.co.kr/en/notice/list.html).
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT® PDRN and DOT® PN. These active tissue regenerative substances are powered by DOT®, an exclusive DNA fragments optimization technology safeguarded by a suite of patents. Headquartered in Seongnam, South Korea, PharmaResearch also operates a U.S. subsidiary, PharmaResearch USA, located in Costa Mesa, California.
Key products include Rejuran®, Rejuviel®, Conjuran®, Rejuran® Cosmetics, Lian® Eye Drops, Rejuvenex Cream®, and Rejuderma®.
For more information about PharmaResearch and its innovative initiatives, visit
http://pharmaresearch.co.kr/en/ and connect with us on LinkedIn.
Media Contact
Company Name: PharmaResearch USA
Contact Person: Sangjin Choi
Email: Send Email
Country: United States
Website: http://pharmaresearch.co.kr/en/